際際滷shows by User: ThomasNL / http://www.slideshare.net/images/logo.gif 際際滷shows by User: ThomasNL / Thu, 07 Jun 2018 13:33:24 GMT 際際滷Share feed for 際際滷shows by User: ThomasNL 2018-05-13 CTCPure - pitchdeck /slideshow/20180513-ctcpure-pitchdeck/101126153 20180513-shortbusinessslides1-180607133324
The challenge: Cancer sucks. Many people suffer from cancer worldwide, but still a large part of the cancer treatments fail. This costs cancer patients lives and brings a large monetary cost to society as well. The challenge is that the effectiveness of cancer therapies can only be seen after weeks. Differences between people give rise to different reactions to therapies. Currently, a mix of drugs is given without knowing if they will work. To examine the effectiveness of drugs on individuals, we present the CTCPure. The solution: The CTCPure isolates and then characterizes circulating tumour cells from the human blood stream. By doing this characterization, a better prognosis and associated treatment can be done for each patient. Instead of determining treatments based on chance of success, treatment will be tailor made to each patient using the CTCPure. By doing this all on one chip, the process is cheap and fool-proof.]]>
The challenge: Cancer sucks. Many people suffer from cancer worldwide, but still a large part of the cancer treatments fail. This costs cancer patients lives and brings a large monetary cost to society as well. The challenge is that the effectiveness of cancer therapies can only be seen after weeks. Differences between people give rise to different reactions to therapies. Currently, a mix of drugs is given without knowing if they will work. To examine the effectiveness of drugs on individuals, we present the CTCPure. The solution: The CTCPure isolates and then characterizes circulating tumour cells from the human blood stream. By doing this characterization, a better prognosis and associated treatment can be done for each patient. Instead of determining treatments based on chance of success, treatment will be tailor made to each patient using the CTCPure. By doing this all on one chip, the process is cheap and fool-proof.]]> Thu, 07 Jun 2018 13:33:24 GMT /slideshow/20180513-ctcpure-pitchdeck/101126153 ThomasNL@slideshare.net(ThomasNL) 2018-05-13 CTCPure - pitchdeck ThomasNL The challenge: Cancer sucks. Many people suffer from cancer worldwide, but still a large part of the cancer treatments fail. This costs cancer patients lives and brings a large monetary cost to society as well. The challenge is that the effectiveness of cancer therapies can only be seen after weeks. Differences between people give rise to different reactions to therapies. Currently, a mix of drugs is given without knowing if they will work. To examine the effectiveness of drugs on individuals, we present the CTCPure. The solution: The CTCPure isolates and then characterizes circulating tumour cells from the human blood stream. By doing this characterization, a better prognosis and associated treatment can be done for each patient. Instead of determining treatments based on chance of success, treatment will be tailor made to each patient using the CTCPure. By doing this all on one chip, the process is cheap and fool-proof. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/20180513-shortbusinessslides1-180607133324-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The challenge: Cancer sucks. Many people suffer from cancer worldwide, but still a large part of the cancer treatments fail. This costs cancer patients lives and brings a large monetary cost to society as well. The challenge is that the effectiveness of cancer therapies can only be seen after weeks. Differences between people give rise to different reactions to therapies. Currently, a mix of drugs is given without knowing if they will work. To examine the effectiveness of drugs on individuals, we present the CTCPure. The solution: The CTCPure isolates and then characterizes circulating tumour cells from the human blood stream. By doing this characterization, a better prognosis and associated treatment can be done for each patient. Instead of determining treatments based on chance of success, treatment will be tailor made to each patient using the CTCPure. By doing this all on one chip, the process is cheap and fool-proof.
2018-05-13 CTCPure - pitchdeck from Thomas Burgers
]]> 35 2 https://cdn.slidesharecdn.com/ss_thumbnails/20180513-shortbusinessslides1-180607133324-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://public.slidesharecdn.com/v2/images/profile-picture.png Hi there!